Treatment of Post-Myocardial Infarction Depressive Disorder: A Randomized, Placebo-Controlled Trial With Mirtazapine
The DOI matches its Crossref record; 97 of the 98 references it cites were found in a registry or an index.
Abstract
Objective: To examine the antidepressant efficacy of a dual-acting antidepressant (mirtazapine) in patients with post-myocardial infarction (MI) depressive disorder. Antidepressants used in post MI trials with a randomized, double-blind, placebo-controlled design have been restricted to selective serotonin reuptake inhibitors (SSRIs). Antidepressant effects have been limited. Methods: In a prospective multicenter study, 2177 patients with MI were evaluated for depressive disorder during the first year post MI. Ninety-one patients who met the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) criteria for major or minor depressive disorder were randomized to a 24-week, double-blind, placebo-controlled trial. Antidepressant efficacy was tested using last-observation-carried-forward procedure and repeated measurements analysis using the SPPS mixed models approach, with as primary outcome reduction in depressive symptomatology on the 17-item Hamilton-Depression Rating Scale (Ham-D), and secondary outcomes the Beck Depression Inventory (BDI) and depression subscale of the Symptom Check List 90 items (dSCL-90) as well as the Clinical Global Impression (CGI) scale. Results: Using the “last observation carried forward” (LOCF) method, mirtazapine did not show to be superior to placebo on the Ham-D, but did on the BDI, dSCL-90, and CGI scale over the acute treatment phase of 8 weeks (n = 91). Using mixed models analysis over the entire 24 weeks of treatment (n = 40), we did find a significant difference favoring mirtazapine to placebo on the Ham-D, BDI, and CGI, but on the dSCL-90, this difference was not significant. Conclusions: This trial shows efficacy of mirtazapine on primary and secondary depression measures. Mirtazapine seems to be safe in the treatment of post-MI depression. MI = myocardial infarction; RCT = randomized controlled trial; DSM-IV = Diagnostic and Statistical Manual of Mental Disorders; CAD = coronary artery disease; SSRI = selective serotonin reuptake inhibitors; TCA = tricyclic antidepressant; Ham-D = Hamilton-Depression Rating Scale; BDI = Beck Depression Inventory; CGI = Clinical Global Impression; dSCL-90 = Symptom Check List 90 items, depression subscale; SES = standardized effect size.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Initial placebo-controlled studies of standard antidepressants (primarily SSRIs) found that these agents were safe and largely effective in the prevention or treatment of major depressive disorder among patients with CVD, 173-177”
From Psychological Health, Well-Being, and the Mind-Heart-Body Connection: A Scientific Statement From the American Heart Association (2021) · cites this paper as [174]
In the citing paper
“but these studies were not powered or designed to detect effects on cardiac risk factors, health behaviors, or cardiac events.”
From Psychological Health, Well-Being, and the Mind-Heart-Body Connection: A Scientific Statement From the American Heart Association (2021) · cites this paper as [174]
In the citing paper
“Antidepressants reduce depressive symptoms in patients with acute coronary syndrome146 but most studies found no benefit in cardiac outcomes147–149.”
From Mechanisms and treatment of late-life depression (2019) · cites this paper as [148]
Citations
Cites
Herne, H., Cooley, W. W., & Lohnes, P. R. (1973) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2344428 · Cited by 35,697
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
(1997) · Chemometrics in Environmental Analysis · doi:10.1002/352760216x.ch5 · Cited by 18,653
(1998) · DigitalCommons - Kennesaw State University (Kennesaw State University) · Cited by 13,997
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Robins, L. N. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800360017003 · Cited by 2,909
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
Depression Following Myocardial Infarction: Impact on 6-Month Survival
Frasure-Smith, N. (1993) · JAMA · doi:10.1001/jama.1993.03510150053029 · Cited by 1,939
'Vascular Depression' Hypothesis
Alexopoulos, G. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830220033006 · Cited by 1,843
Research works printed but not linked: 1
- Case, 1992, Living alone after myocardial infarction., JAMA, 267, 515, 10.1001/jama.1992.03480040063031 · DOI · Paper page
Cited by
Items 101–184 of 184
Identifying and managing depression in patients with coronary artery disease
Pragle, A. S., & Salahshor, S. (2018) · JAAPA · doi:10.1097/01.jaa.0000532111.83132.8b · Cited by 9
How Should We Treat Depression in Patients with Cardiovascular Disease?
Kronish, I. M., Krupka, D. J., & Davidson, K. W. (2012) · Dialogues in Cardiovascular Medicine · doi:10.7916/d8vd6zg2 · Cited by 9
Depression and Anxiety Disorders
Karamustafalıoğlu, O., & Yumrukçal, H. (2025) · Wiley eBooks · doi:10.1002/9781119870203.mpg003.pub2 · Cited by 8
Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression
Gartlehner, G., Hansen, R. A., Morgan, L. C., Thaler, K. J., Lux, L. J., Noord, M. V., Mager, U., Gaynes, B. N., Thieda, P., Strobelberger, M., et al. (2011) · Cited by 8
Lim, G. E. H., Tang, A. S. P., Chin, Y. H., Yong, J. N., Tan, D. J. H., Tay, P. W. L., Chan, Y. Y., Lim, D. M. W., Yeo, J. W., Chan, K. E., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278326 · Cited by 8
Treatment of post-myocardial infarction depressive disorder
Kuyper, A. M. G., & Honig, A. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.7.1115 · Cited by 8
Self-citationPsychische Störungen bei somatischen Krankheiten
Kapfhammer, H. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_88 · Cited by 7
McIntyre, R. S., Fayyad, R. S., Mackell, J. A., & Boucher, M. (2016) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1136603 · Cited by 7
A Narrative Review of the Relationship Between Coronary Heart Disease and Anxiety
Dahale, A. B., Menon, J. C., & Jaisoorya, T. S. (2017) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.5812/ijpbs.7722 · Cited by 6
Depression treatment and coronary artery disease outcomes: Time for reflection
Shapiro, P. A. (2012) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2012.11.008 · Cited by 6
Meta-analysis of placebo group dropout in adult antidepressant trials
Li, F., Nasir, M., Olten, B., & Bloch, M. H. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109777 · Cited by 5
Davis, M. P. (2020) · Springer eBooks · doi:10.1007/978-3-319-56015-1_102-1 · Cited by 5
Malik, J., Khan, H. S., Younus, F., & Shoaib, M. (2020) · Pulse · doi:10.1159/000516415 · Cited by 5
Tian, Y., Zhang, J., Zhao, Y., Mao, J., Zhu, L., Gao, R., Wang, X., Zhu, M., Ma, L., Zhao, M., et al. (2018) · Trials · doi:10.1186/s13063-018-2950-7 · Cited by 5
Gulfishan, S., Halder, S., Kar, R., Srivastava, S., & Gupta, R. (2022) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2833 · Cited by 5
The Psychiatric Management of Patients with Cardiac Disease
Maytal, G., Huffman, J. C., Januzzi, J. L., & Stern, T. A. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-1927-7.00023-6 · Cited by 4
Sim, T. F., Marashdeh, R. M., & Parsons, R. W. (2019) · Journal of Research in Pharmacy Practice · doi:10.4103/jrpp.jrpp_18_63 · Cited by 4
Depression and Cardiovascular Disease Progression: Epidemiology, Mechanisms and Treatment
Hoen, P. W., Kupper, N. H. M., & de Jonge, P. (2011) · Springer eBooks · doi:10.1007/978-1-84882-419-5_12 · Cited by 4
Predictors of Start of Different Antidepressants in Patient Charts Among Patients with Depression
Kim, H. M., Zivin, K., Choe, H. M., Stano, C. M., Ganoczy, D. A., Walters, H., & Valenstein, M. M. (2015) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2015.21.5.424 · Cited by 4
Glassman, A. H., & Bigger, J. T. (2010) · Wiley eBooks · doi:10.1002/9780470972304.ch5 · Cited by 3
Lázaro, E. V. (2024) · Psykhe (Santiago) · doi:10.7764/psykhe.2021.44719 · Cited by 3
Alosaimi, F. D., & Baker, B. (2012) · Saudi Medical Journal · doi:10.15537/1658-3175.5648 · Cited by 3
Perez-Parada, J. (2011) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5350/kpb-bcp201121102 · Cited by 3
Psychische Störungen bei somatischen Krankheiten
Kapfhammer, H. (2015) · Springer eBooks · doi:10.1007/978-3-642-45028-0_88-1 · Cited by 2
Eyre, H. A., Forbes, M., Lavretsky, H., & Baune, B. T. (2016) · Springer eBooks · doi:10.1007/978-3-319-32480-7_23 · Cited by 2
Depression in the context of physical illness
Gastelum, E. D., Muskin, P. R., & Shapiro, P. A. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.013 · Cited by 2
Heart Failure: Psychological and Pharmacological Considerations
Celano, C. M., Villegas, A. C., Albanese, A. M., & Huffman, J. C. (2016) · Psychiatric Annals · doi:10.3928/00485713-20161102-01 · Cited by 2
Patel, P., Yang, F., Iacobaş, D. A., & Xi, L. (2024) · 老年心脏病学杂志:英文版 · doi:10.26599/1671-5411.2024.09.004 · Cited by 2
Srivastava, I., Khurana, P., Yadav, M., & Hasija, Y. (2017) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2017.07.016 · Cited by 2
Depressie: een nieuwe risicofactor voor hart- en vaatziekten
van Weert, H. C. P. M. (2008) · TvPO · doi:10.1007/bf03086499 · Cited by 2
Drug classification for patients with comorbidities
Fi, B. (2022) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-022-00453-9 · Cited by 2
Lundgren, O. (2018) · Linköping University medical dissertations · doi:10.3384/diss.diva-148332 · Cited by 1
Bueno, A., & Simón, M. A. (2024) · Behavioral Psychology/Psicología Conductual · doi:10.51668/bp.8324104n · Cited by 1
Depression and Anxiety Disorders
(2021) · Wiley eBooks · doi:10.1002/9781119870203.mpg003 · Cited by 1
Psychosocial Issues in Cardiovascular Disease
Luberto, C. M., Park, E. R., Huffman, J. C., & Yeh, G. Y. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819369-3.00025-3 · Cited by 1
Kapfhammer, H. (2022) · Springer eBooks · doi:10.1007/978-3-662-65873-4_2 · Cited by 1
Poostchi, A. J., Collett, G., & Gupta, A. K. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag144 · Cited by 1
Management of major depressive disorder in primary care.
Dantz, B. (2008) · PubMed · Cited by 1
Psychokardiologie – aus praktischer und klinischer Sicht
Langheim, E., Langner, P., & Köllner, V. (2024) · Die Rehabilitation · doi:10.1055/a-2186-4285 · Cited by 1
Consultation-Liaison Psychiatry and Psychological Factors Affecting Other Medical Conditions
McFarland, D. C., & Alici, Y. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_90 · Cited by 1
Consultation-Liaison Psychiatry and Psychological Factors Affecting Other Medical Conditions
McFarland, D. C., & Alici, Y. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_90-1 · Cited by 1
Psychiatric Aspects of Heart and Lung Disease in Critical Care
Shapiro, P. A., Fedoronko, D. A., Epstein, L. A., Mirasol, E. G. E., & Desai, C. V. (2010) · Heart Failure Clinics · doi:10.1016/j.hfc.2010.10.002 · Cited by 1
Mirtazapine in veterinary medicine: focus on its role in gastrointestinal disorders - review
Zalischi, D. B., Bel, L. V., Ștefănuț, L. C., Catană, L., & CERNEA, M. S. (2025) · Romanian Journal of Veterinary Sciences · doi:10.59463/rjvs.2025.2.20 · Cited by 1
de Jonge, P. (2009) · Psychologie & gezondheid · doi:10.1007/bf03080359 · Cited by 1
Wenn das Herz auf die Psyche schlägt: Über den Zusammenhang von Depression und KHK
Lange‐Asschenfeldt, C., & Lederbogen, F. (2013) · CME · doi:10.1007/s11298-013-0368-9 · Cited by 1
Cardoso, A., Quagliato, L. A., Horato, N., Dutra, P. E. P., & Nardi, A. E. (2024) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2024.2409434 · Cited by 1
Patron, E. (2014) · Padua@research (University of Padova) · Cited by 1
Uranga, I. U., Bengoetxea, M. B., Unanue, G. E., Hernando, M. E., & Martin, A. I. (2011) · Enfermería en cardiología: revista científica e informativa de la Asociación Española de Enfermería en Cardiología · Cited by 1
Cortical processing of pain : a bridge between experimental findings and clinical implications
Vossen, H. G. M. (2010) · Research Publications (Maastricht University) · doi:10.26481/dis.20100331hv · Cited by 1
Self-citationDepression, antidepressants and heart disease
(2008) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2008.03.0009 · Cited by 1
Cardiac Rehabilitation After Acute Myocardial Infarction: The Influence of Psychosocial Disorders
Benzer, W. (2010) · Springer eBooks · doi:10.1007/978-1-84882-794-3_7 · Cited by 1
Omega-3 Fatty Acids and Depressive Symptoms in Coronary Artery Disease
Mazereeuw, G. (2015) · TSpace (University of Toronto) · Cited by 1
Duncan, E., Hersant, H., & Khairova, R. A. (2026) · Springer eBooks · doi:10.1007/978-3-032-15772-0_4
Cardiovascular side effects of non-SSRI antidepressants are of concern in high-risk patients
Kang, C. (2022) · Drugs & Therapy Perspectives · doi:10.1007/s40267-022-00927-5
McGrath, P. J., & Roose, S. P. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.004
Kahl, K. G., Deuschle, M., & Schneider, F. (2026) · Springer eBooks · doi:10.1007/978-3-662-70668-8_40
Davis, M. P. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_102
Gamage, C. K. W., de Zoysa, P. T., Balasuriya, A., & Fernando, N. (2024) · Discover Mental Health · doi:10.1007/s44192-024-00080-7
Affektív temperamentumok: híd a major affektív és a szív - érrendszeri betegségek között
Eőry, A. (2015) · Semmelweis University Repository (Semmelweis University) · doi:10.14753/se.2015.1777
Positionspapier zur Bedeutung psychosozialer Faktoren in der Kardiologie
München, Z., Würzburg, U., Medizinische, I., Wuppertal-Herzzentrum, H.-K., & Ulm, U. (2013)
Machine learning for large observational datasets in healthcare
Morel, M. (2021) · theses.fr (ABES) · doi:10.70675/4c309e60zdba1z4d73za007zbd512e238110
Perspectives on percutaneous coronary intervention : More than just coronary arteries?
Damen, N. L. (2014) · Research portal (Tilburg University)
Psychiatric Management of Patients with Cardiac Disease
Zambrano, J., Beach, S. R., Celano, C. M., Huffman, J. C., Januzzi, J. L., & Stern, T. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-11844-9.00040-0
Shapiro, P. A. (2018) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371990.jl17
Adibfar, A. (2016) · TSpace (University of Toronto)
Psychosomatic Medicine and Psychological Factors Affecting Other Medical Conditions
Levenson, J. L., & Bledowski, J. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch116
Ketterer, M. W. (2008) · The Journal of Cardiovascular Nursing · doi:10.1097/01.jcn.0000305063.34366.09
Kerber, K. A., Taylor, K., & Riba, M. B. (2011) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378197.lg07
Current awareness in human psychopharmacology
(2008) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.889
Cardiac Rehabilitation After Acute Myocardial Infarction: The Influence of Psychosocial Disorders
Benzer, W. (2017) · Springer eBooks · doi:10.1007/978-3-319-47738-1_7
Особенности терапевтического выбора антидепрессантов в кардиологической практике: обзор литературы
Golyshko, V. S., Балабанович, Т. И., & Savitski, I. S. (2025) · Кардиология в Беларуси · doi:10.34883/pi.2025.17.6.012
Mirtazapine Review of its Use in Major Depression and Other
Kluwer, W., Anghelescu, I. G., Ishigooka, J., Kasper, S. F., Suzuki, T., & Uchida, H. (2009)
Welsh, J. (2020) · ANU Open Research (Australian National University) · doi:10.25911/5eeb43ba0e01b
Alaamri, S., Serafi, A. S., Azmat, A., Ahmed, M., Bafail, M. A., & Siddiqui, U. N. (2026) · Journal Of Advanced Pharmacy Education And Research · doi:10.51847/gyihggtdk7
Çocuk ve Ergenlerde Konsültasyon-Liyezon Psikiyatrisi
Yamak, Y. H., Kurt, Z. K., Demir, G., Torun, Y. T., Özhan, C. Ç., Becer, B., Demirci, S. C., Gürbüz, Ş., Kılıçaslan, S., Cengiz, Ş. N. K., et al. (2026) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3558
Lui, H. (2017) · eScholarship (California Digital Library)
(2011) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378135.lg17
MacGregor, S. N. (2016) · YorkSpace (York University)
Chapter 6. Cardiovascular Disorders
(2023) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375264.lg06
Bhimaraj, A. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717976267.793472363
Platelet Activating Factors and Depressive Symptoms in Coronary Artery Disease Patients
Mazereeuw, G. (2013) · TSpace (University of Toronto)
Wise, T. N. (2012) · Psychosomatics · doi:10.1016/j.psym.2011.12.004
Metadata
- Authors
- Honig, A., Kuyper, A. M. G., Schene, A. H., van Melle, J. P., de Jonge, P., Tulner, D. M., Schins, A., Crijns, H. J. G. M., Kuijpers, P. M. J. C., Vossen, H., Lousberg, R., & Ormel, J.
- Affiliations
- Sint Lucas Andreas Hospital (NL)
- Corresponding author
- Honig, Adriaan
- Venue
- Psychosomatic Medicine
- Published
- 2007-09
- Volume
- 69
- Issue
- 7
- Pages
- 606-613
- ISSN
- 0033-3174 (ISSN-L)
- OpenAlex
- W2168362160
- Cited by
- 167
- References
- 98
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 8 · 2023: 5 · 2022: 9 · 2021: 9 · 2020: 6 · 2019: 4 · 2018: 9 · 2017: 8 · 2016: 4 · 2015: 13 · 2014: 3 · 2013: 15 · 2012: 12
- FWCI
- 8.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychosomatic Medicine (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- mirtazapine, post-myocardial infarction depression, depressive disorders, antidepressant efficacy, major depressive disorder, placebo comparison, depression symptom reduction, coronary artery disease, antidepressant safety, selective serotonin reuptake inhibitors, tricyclic antidepressants, Hamilton Depression Rating Scale
- MeSH terms
- Mirtazapine, Aged, Depressive Disorder, Double-Blind Method, Female, Humans, Male, Mianserin, Middle Aged, Myocardial Infarction, Antidepressive Agents, Second-Generation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.